Importantly, MYC is found to bind to and regulate SOX2 gene expression in CSCs derived from triple negative breast cancer, suggesting MYC can regulate cancer stemness by modulating the expression of other critical embryonic stem cell markers such as Sox2 [36]. The gene discussed is MYC; the disease is triple-negative breast carcinoma.